Introduction
Thoma Bravo's software portfolio, more than 75 companies when the firm closed three buyout funds in June 2025, generated about $30 billion of annual revenue and employed over 93,000 people, according to Thoma Bravo's fundraising announcement. Read as one business, that is a large software company, run by a firm that has acquired or invested in roughly 535 companies over two decades. That is the defining fact about a sector specialist sponsor: it sees its industry from the inside, through dozens of sets of monthly numbers, pricing decisions and management teams, and it usually knows the sector's operating detail better than the bank calling on it. Specialists exist in most large sectors, from software (Thoma Bravo, Vista, Francisco Partners, and Silver Lake across technology more broadly) to healthcare (Welsh Carson, Linden) and consumer (Sycamore, L Catterton). Serving them changes the division of labor inside a bank and the financing it offers.
How the Specialist Model Works
A specialist runs the ordinary buyout model inside one industry, or a pair of adjacent ones, and builds the whole firm around that choice. Its fund family is sized to cover the sector at several scales: the June 2025 close comprised the $24.3 billion Thoma Bravo Fund XVI, the $8.1 billion Discover Fund V, the firm's middle-market strategy, and a first Europe fund of about €1.8 billion, all aimed at software. The boundary is not always one sector. Welsh Carson invests in healthcare and technology, Silver Lake across technology rather than software alone, and L Catterton, which is affiliated with the French luxury group LVMH, across consumer brands through separate buyout and growth strategies.
- Sector Specialist Sponsor
A private equity firm that invests in one industry, or a small set of adjacent ones, across all of its funds, and builds its operating teams, deal sourcing and add-on programs around that sector. Generalist sponsors run sector teams too, but at a specialist the whole firm, not one team inside it, depends on the sector.
Three habits follow from that focus, and each one shapes what the firm buys from a bank.
Repeatable Playbooks and Operating Teams
Specialization pays when a firm can run the same improvements across many companies. Vista Equity Partners reports a value creation team of more than 100 dedicated consultants, organized in five practice areas from go-to-market to finance, and more than 100 codified best practices, against 85-plus portfolio companies and $103 billion of assets under management (AUM) at June 30, 2026. A repeatable playbook of this kind also turns the portfolio into a private benchmark set: pricing, sales productivity and product spending for dozens of comparable companies. The levers themselves are covered in the sponsor value creation playbook, and their software version in the technology guide's take-private article.
Platforms, Add-Ons and the Sector Network
The second habit is buy-and-build. Linden Capital Partners, which calls itself the largest dedicated healthcare private equity manager, reported more than 350 transactions across more than 45 healthcare companies when it closed its sixth fund at $5.4 billion in April 2025, per Linden's fund announcement. Roughly eight transactions for every company owned is the arithmetic of a platform-and-add-on strategy, examined from the fund's side in the buy-and-build article.
The third is the sector network: executives and advisers a firm can place into a new company. When Sycamore Partners, a consumer and retail specialist, completed its take-private of Walgreens Boots Alliance on August 28, 2025, it split the group into five standalone companies and named Mike Motz, formerly chief executive of Sycamore's own Staples US Retail and before that president of the Canadian pharmacy chain Shoppers Drug Mart, to run Walgreens, Supermarket News reported. Depth has a cost too: serial add-ons in one market draw antitrust scrutiny, and Welsh Carson's January 2025 settlement with the Federal Trade Commission (FTC) over its anesthesia roll-up, set out in the healthcare guide's antitrust article, requires prior approval for its future anesthesia investments.
Specialists by Sector and What They Ask of a Bank
Specialists cluster where an industry has many similar companies, a repeatable improvement thesis and predictable cash flows to borrow against. The table pairs the main specialist families with what the bank's industry group has to bring and the financing each sector tends to use. The last column shows tendencies, not rules.
| Sector | Specialist sponsors | What the industry group brings | Financing the sector tends to use |
|---|---|---|---|
| Software and technology | Thoma Bravo, Vista, Francisco Partners, Silver Lake | Public software comparables, strategic buyer appetite, subscription metrics | Recurring revenue loans for low-profit targets; term loans for mature cash generators |
| Healthcare | Welsh Carson, Linden | Reimbursement and regulatory knowledge, add-on target maps, antitrust screening | Delayed-draw and incremental capacity for add-ons |
| Consumer and retail | Sycamore, L Catterton | Brand and retail comparables, store and real estate data, consumer strategic buyers | Asset-based loans secured by inventory and receivables |
Two cautions keep the table honest. Specialists are not confined to their row's financing: Thoma Bravo's $5.5 billion Dayforce term loan, covered in the comparison of sponsor coverage with leveraged finance, was a bank-led buyout loan for a profitable software company. And generalist sponsors with sector teams bid for the same assets, so a specialist's edge is depth across the firm, not exclusive access to its industry.
Industry Content, Coverage Relationship: Who Carries What
On a specialist account the industry group usually carries the content: comparables, buyer lists, add-on screens and the sector's regulatory calendar. The coverage banker carries the relationship, tracks which fund and which partner is active, and coordinates financing across the bank, the general split that the coverage triangle describes. Banks draw the line differently. Some let a senior technology or healthcare banker own a specialist outright, with the sponsors group in support; others keep the specialist inside sponsor coverage and pull in the industry team deal by deal.
When the Client Knows the Sector Better
A specialist partner who has owned a dozen companies in a subsector has seen their monthly numbers, which no bank has. The bank's value lies in what one owner cannot see from inside its own portfolio: which strategic acquirers are actively buying, how rival sponsors bid in recent processes, what lenders will advance against the sector this month, and how public investors are pricing comparable companies.
Who Advises on a Specialist Deal
The adviser line-up on a specialist take-private shows both relationships at work. When Francisco Partners, which describes itself as specializing in technology and technology-enabled businesses, agreed with TPG in July 2023 to take New Relic private for $87 a share, about $6.5 billion of equity value, the deal announcement named Morgan Stanley as lead financial adviser to the buyers, with Goldman Sachs, J.P. Morgan and Moelis also advising, while the technology boutique Qatalyst Partners advised New Relic. A specialist and a generalist (TPG invested through its TPG Capital buyout platform) shared the equity, and four banks shared the buy-side advisory roles.
Financing Built Around How the Sector Earns Cash
Specialists push banks toward financing shaped by the sector, and software shows it well. A fast-growing software company can spend heavily on sales and product and report little earnings before interest, taxes, depreciation and amortization (EBITDA) while holding years of contracted subscription revenue, so lenders built a loan sized on revenue instead.
- Recurring Revenue Loan
A leveraged loan to a subscription business, usually software, sized and tested against annual recurring revenue (ARR) rather than EBITDA. Its covenants typically convert to a conventional EBITDA test after a set period, by which time the borrower is expected to be solidly profitable.
These loans are mainly a private credit product. Kroll Bond Rating Agency (KBRA) describes them as a lending strategy focused on high-growth software companies, and its June 2025 performance review of 189 companies assessed between 2023 and early 2025 found relatively few lender losses, flagged 16% of the group as underperforming, and counted eight borrowers whose covenants flipped from ARR to EBITDA in the first quarter of 2025 alone. For coverage, the covenant flip is the date to track: a company moving to EBITDA tests is often ready for a larger, cheaper financing, and that is a refinancing mandate. Consumer specialists lean on different collateral, typically asset-based loans whose availability rises and falls with inventory and receivables.
Direct Lenders and the Specialists' Own Credit Arms
New Relic shows where the debt can go. At closing in November 2023 the buyers took a $2.4 billion term loan and put in place a $250 million revolving facility under a credit agreement with Blue Owl Capital Corporation as administrative agent, New Relic's closing filing shows, beside a $4.02 billion equity commitment from the Francisco Partners and TPG funds disclosed in the merger proxy: banks advised, and private credit lenders supplied the debt. Some specialists also lend. Thoma Bravo runs a credit strategy beside its buyout and growth funds, and Vista reports that its private credit business has deployed more than $16.9 billion across over 750 investments and works with more than 80 private equity firms, so a specialist can be a bank's client on one software deal and a competing lender on another sponsor's.
When the Whole Portfolio Moves Together
Specialization concentrates risk as well as knowledge. When software valuations fell between 2024 and 2026 amid fears of disruption from artificial intelligence, the change reached every specialist software portfolio at once, the pattern traced in the software valuation reset; at the extreme, lenders took control of Vista's Pluralsight in 2024, an episode recorded in the sponsor universe map.
That correlation sets the rhythm of the account. A generalist's portfolio companies come to market on staggered timetables; a specialist's tend to move when its sector's financing window opens or shuts. A bank that tracks the sector's own cycle (its valuation multiples, its lenders' appetite, its active strategic buyers) beside the sponsor's fund cycle will know when a specialist's whole book is about to call.
